Key statistics
On Friday, Prime Medicine Inc (PRME:NMQ) closed at 3.30, 197.30% above the 52 week low of 1.11 set on May 22, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 3.35 |
|---|---|
| High | 3.47 |
| Low | 3.28 |
| Bid | 3.27 |
| Offer | 3.30 |
| Previous close | 3.32 |
| Average volume | 2.59m |
|---|---|
| Shares outstanding | 180.51m |
| Free float | 148.70m |
| P/E (TTM) | -- |
| Market cap | 595.69m USD |
| EPS (TTM) | -1.44 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
- Prime Medicine to Present at 44th Annual J.P. Morgan Healthcare Conference
- Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease
- Prime Medicine to Present at 8th Annual Evercore Healthcare Conference
- Prime Medicine to Present at Jefferies Global Healthcare Conference
- CORRECTION - Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates
- Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates
- Prime Medicine Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer
- Prime Medicine to Host Virtual KOL Event to Showcase Wilson’s Disease Strategy
- Prime Medicine to Participate in Upcoming Investor Conferences
- Prime Medicine to Participate in Upcoming Investor Conferences
More ▼
